Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Deals and Financings
Simcere Pharma...
The World Health Organization approved Sinopharm's...
COVID-19 Pandemic
WHO approved Sinopharm's...
Advaccine Biopharma Suzhou and Sinovac...
Deals and Financings
Yantai's RemeGen...
Deals and Financings
France's Sanofi will...
Shanghai Clover Biopharma has started a Phase III trial...
Including Private and Public Companies. More details...
Two familiar themes ran through China life science news...
Last week, experts with experience in China life science...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China